The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers
Authors
Keywords
Prostate cancer, Messenger RNA, Luciferase, Protein translation, Prostate gland, Androgens, DU145 cells, Protein expression
Journal
PLoS One
Volume 8, Issue 1, Pages e54251
Publisher
Public Library of Science (PLoS)
Online
2013-01-17
DOI
10.1371/journal.pone.0054251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA Regulation of Oncolytic Adenovirus 6 for Selective Treatment of Castration-Resistant Prostate Cancer
- (2012) Z. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer
- (2011) P. P. Singh et al. CLINICAL CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety
- (2011) Himisha Beltran et al. EUROPEAN UROLOGY
- TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
- (2011) Daniel C. Danila et al. EUROPEAN UROLOGY
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Impact of Hypoxia on the Metastatic Potential of Human Prostate Cancer Cells
- (2011) Yao Dai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
- (2011) Elizabeth A. Platz et al. Cancer Discovery
- HIF1α isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation
- (2010) Nastaran Monsef et al. BMC CANCER
- The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers
- (2010) R Foley et al. CANCER BIOLOGY & THERAPY
- Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment
- (2010) Takakazu Mitani et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
- (2010) Hiroshi Tanaka et al. NATURE MEDICINE
- Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
- (2010) Nadine Rohwer et al. PLoS One
- Role of 5′- and 3′-untranslated regions of mRNAs in human diseases
- (2009) Sangeeta Chatterjee et al. BIOLOGY OF THE CELL
- Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer
- (2009) K. Gravdal et al. CANCER RESEARCH
- Targeting the hypoxia-inducible factor (HIF) pathway in cancer
- (2009) Evon Poon et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions
- (2009) Caroline N Mills et al. Molecular Cancer
- G-rich Oligonucleotides Inhibit HIF-1α and HIF-2α and Block Tumor Growth
- (2009) Yongli Guan et al. MOLECULAR THERAPY
- Expression and Localization of Hypoxia Proteins in Prostate Cancer: Prognostic Implications After Radical Prostatectomy
- (2009) Judith Jans et al. UROLOGY
- HIF-1αmRNA gene expression levels in improved diagnosis of early stages of prostate cancer
- (2008) Christodoulos P. Pipinikas et al. BIOMARKERS
- Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
- (2008) Robert W. Ross et al. CANCER
- Hypoxia in prostate cancer: A powerful shield against tumour destruction?
- (2008) L. Marignol et al. CANCER TREATMENT REVIEWS
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
- (2008) Roy Vergis et al. LANCET ONCOLOGY
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now